Getting The Wrinkles Out Of Anti-Aging Products

Law360, New York (March 11, 2013, 12:35 PM EDT) -- Lately, the cosmetics industry — particularly with respect to anti-aging products — has been a popular target for both the U.S. Food and Drug Administration and plaintiffs. Because FDA warning letters and lawsuits can create unwanted press and costs for companies, it is important for inside and outside counsel to work together to recognize potential risks of increased FDA scrutiny and the potential consequent risk of future class actions lawsuits.

FDA Warning Letters to Anti-Aging Product Manufacturers

In the fall of 2012, the FDA was busy admonishing...
To view the full article, register now.